Multicenter Study of the Safety and Efficacy of NAFT-500 in Tinea Pedis
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
A research study to compare the safety and effectiveness of an investigational medication
called NAFT-500 to placebo, when used in subjects with tinea pedis (athlete's foot).
Phase:
Phase 3
Details
Lead Sponsor:
Merz North America, Inc. Merz Pharmaceuticals, LLC